| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |